Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by IGUCHI KIMI, Chief Financial Officer. Director active across 1 company, notably Sage Therapeutics, Inc.. Cumulatively, 19 filings have been logged. Split: 1 buy · 0 sell. Activity tracked since 15 June 2021. The latest transaction was filed on 5 August 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Kimi Iguchi is the CFO & Treasurer at Sage Therapeutics, Inc. In this role, she oversees the financial management of the company and ensures compliance with financial regulations. Her expertise in finance is crucial for supporting the company's growth and strategy.